SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

LifeStance Reports Third-Quarter Results, Raises Full-Year Outlook

LFST
SquawkNews Desk 2 updates Updated Nov 05, 2026, 11:15 AM UTC

Story updates

11:07:22 AM UTC
SquawkNews
LifeStance Health Group Raises 2026 View To Rev $1.74B-$1.76B >LFST
11:15:21 AM UTC
SquawkNews
LifeStance Health Q3 revenue beats on clinician growth, lifts FY outlook

Related stories

Lemonade Raises GEP and Revenue Guidance, Expects Positive Q4 Adjusted EBITDA Lemonade reiterated its FY IFP guidance and raised its GEP and revenue guidance. It expects positive adjusted EBITDA in Q4 2026. M impact | EQUITY | Nov 05, 2026, 11:29 AM UTC LifeStance Health Reports Q3 EPS of $0.06 M impact | EARNINGS | Nov 05, 2026, 11:24 AM UTC Lemonade Q3 Revenue Beats Estimates on Premium Growth M impact | EQUITY | Nov 05, 2026, 11:23 AM UTC LifeStance Health Expects 2026 Revenue of $1.74B to $1.76B LifeStance Health expects 2026 revenue of $1.74 billion to $1.76 billion, versus a FactSet estimate of $1.71 billion. M impact | EARNINGS | Nov 05, 2026, 11:23 AM UTC AtkinsRealis Reports Q3 Revenue of CA$3.11B AtkinsRealis Group reported Q3 revenue of CA$3.11B, versus a FactSet estimate of CA$3.02B. M impact | EQUITY | Nov 05, 2026, 11:23 AM UTC Titan Co Approves Proposal for NCDs Up to 25 Billion Rupees M impact | EQUITY | Nov 05, 2026, 11:23 AM UTC